- Home
- AUPH vs PARR Comparison
AUPH vs PARR Comparison
Compare AUPH & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- PARR
- Stock Information
- Founded
- AUPH 1993
- PARR 1984
- Country
- AUPH Canada
- PARR United States
- Employees
- AUPH N/A
- PARR N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- PARR Integrated oil Companies
- Sector
- AUPH Health Care
- PARR Energy
- Exchange
- AUPH Nasdaq
- PARR Nasdaq
- Market Cap
- AUPH 1.4B
- PARR 1.5B
- IPO Year
- AUPH 1999
- PARR N/A
- Fundamental
- Price
- AUPH $12.22
- PARR $33.26
- Analyst Decision
- AUPH Strong Buy
- PARR Hold
- Analyst Count
- AUPH 4
- PARR 6
- Target Price
- AUPH $12.25
- PARR $25.79
- AVG Volume (30 Days)
- AUPH 1.7M
- PARR 1.7M
- Earning Date
- AUPH 11-06-2025
- PARR 11-03-2025
- Dividend Yield
- AUPH N/A
- PARR N/A
- EPS Growth
- AUPH N/A
- PARR N/A
- EPS
- AUPH 0.42
- PARR N/A
- Revenue
- AUPH $260,111,000.00
- PARR $7,614,628,000.00
- Revenue This Year
- AUPH $16.92
- PARR N/A
- Revenue Next Year
- AUPH $14.29
- PARR N/A
- P/E Ratio
- AUPH $29.10
- PARR N/A
- Revenue Growth
- AUPH 25.59
- PARR N/A
- 52 Week Low
- AUPH $6.42
- PARR $11.86
- 52 Week High
- AUPH $12.82
- PARR $36.26
- Technical
- Relative Strength Index (RSI)
- AUPH 61.79
- PARR 53.28
- Support Level
- AUPH $11.57
- PARR $32.70
- Resistance Level
- AUPH $12.82
- PARR $36.26
- Average True Range (ATR)
- AUPH 0.36
- PARR 1.82
- MACD
- AUPH -0.10
- PARR 0.11
- Stochastic Oscillator
- AUPH 52.08
- PARR 64.37
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.